100th つないで、進む FRONTIERS IN LIFE SCIENCE

検索の使い方

Breast Cancer Mid-density Tissue Array, Non-overlapping With Either BRC1501 Or BRC1503, 75 Cases/150 Cores|ヒト組織アレイ

掲載日情報：2015/08/07 現在Webページ番号：172923

ティッシューアレイドットコム /
TissueArray.Com LLC
[メーカー略称：USB]

US Biomax社は、豊富なラインナップの組織アレイ、組織切片(凍結、FFPE)を提供しているメーカーです。
US Biomax社のヒト組織アレイ(Breast Cancer Mid-density Tissue Array, Non-overlapping With Either BRC1501 Or BRC1503, 75 Cases/150 Cores)をご紹介します。

※ヒト組織アレイは、ドナーからインフォームドコンセントを取得した組織を使用しています。
※ドナーの組織は、HIV、Hepatitis B、Hepatitis Cが陰性であることを確認しています。
※本製品は研究用です。研究用以外には使用できません。

カートに商品を
追加しました。

ヒト組織アレイの価格

[在庫・価格 ：2024年06月05日 20時55分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 商品名
  • 商品コード
  • メーカー
  • 包装
  • 価格
  • 在庫
  • 法規制等
 納期 文献数
Breast cancer mid-density tissue array, non-overlapping with BRC1501, 75 cases/150 cores
  • お問い合わせ
 2～3週間 ※※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 0
  • お問い合わせ
説明文
法規制等
保存条件 室温,暗所保存 法規備考
掲載カタログ

製品記事 TissueArray.Com社 組織アレイ(Tissue array) 選択ガイド
関連記事 TissueArray.Com社 パラフィン組織スライド／組織アレイの仕様変更につきまして

[在庫・価格 ：2024年06月05日 20時55分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

Breast cancer mid-density tissue array, non-overlapping with BRC1501, 75 cases/150 cores

文献数： 0

  • お問い合わせ

説明文
法規制等
保存条件 室温,暗所保存 法規備考
掲載カタログ

製品記事 TissueArray.Com社 組織アレイ(Tissue array) 選択ガイド
関連記事 TissueArray.Com社 パラフィン組織スライド／組織アレイの仕様変更につきまして
  • お問い合わせ

目次に戻る

カートに商品を
追加しました。

ヒト組織アレイの特長

Microarray Panel: Breast cancer tissue microarray, including 75 cases of normal, reactive, premalignant and malignant (various grades and stages) tissues of the breast in duplicates
Cores: 150
組織アレイ
Cases: 75
Layout: 15 cols × 10 rows
Core Diameter: 1.1 mm
Thickness: 4 µm
Quality Control: H&E, IHC anti-Cytokeratin
Applications:

Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes: Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H and E: Hematoxylin and Eosin stained tissue array slide.

目次に戻る

カートに商品を
追加しました。

ヒト組織アレイの仕様表

Pos No. Sex Age Organ Pathology diagnosis Grade TNM Type †
A1 1 F 47 Breast Normal, hyperplasia Normal
A2 2 F 40 Breast Normal, hyperplasia Normal
A3 3 F 42 Breast Normal, hyperplasia Normal
A4 4 F 16 Breast Fibroadenoma Benign
A5 5 F 50 Breast Fibroadenoma Benign
A6 6 F 35 Breast Invasive ductal carcinoma III T4N0M0 Malignant
A7 7 F 40 Breast Invasive ductal carcinoma II T3N0M0 Malignant
A8 8 F 53 Breast Ductal carcinoma in situ I T3N0M0 Malignant
A9 9 F 45 Breast Ductal carcinoma in situ I T3N0M0 Malignant
A10 10 F 56 Breast Invasive ductal carcinoma II T2N0M0 Malignant
A11 11 F 33 Breast Invasive ductal carcinoma II T2N0M0 Malignant
A12 12 F 37 Breast Invasive ductal carcinoma II~III T3N2M0 Malignant
A13 13 F 50 Breast Invasive ductal carcinoma II T3N0M0 Malignant
A14 14 F 64 Breast Invasive tubular carcinoma II~III T4N1M0 Malignant
A15 15 F 44 Breast Invasive ductal carcinoma II T3N1M0 Malignant
B1 16 F 47 Breast Normal, hyperplasia Normal
B2 17 F 40 Breast Normal, hyperplasia Normal
B3 18 F 42 Breast Normal, hyperplasia Normal
B4 19 F 16 Breast Fibroadenoma Benign
B5 20 F 50 Breast Fibroadenoma Benign
B6 21 F 35 Breast Invasive ductal carcinoma III T4N0M0 Malignant
B7 22 F 40 Breast Invasive ductal carcinoma II T3N0M0 Malignant
B8 23 F 53 Breast Ductal carcinoma in situ I T3N0M0 Malignant
B9 24 F 45 Breast Ductal carcinoma in situ I T3N0M0 Malignant
B10 25 F 56 Breast Invasive ductal carcinoma II T2N0M0 Malignant
B11 26 F 33 Breast Invasive ductal carcinoma II T2N0M0 Malignant
B12 27 F 37 Breast Invasive ductal carcinoma II~III T3N2M0 Malignant
B13 28 F 50 Breast Invasive ductal carcinoma II T3N0M0 Malignant
B14 29 F 64 Breast Invasive tubular carcinoma II~III T4N1M0 Malignant
B15 30 F 44 Breast Invasive ductal carcinoma II T3N1M0 Malignant
C1 31 F 55 Breast Invasive ductal carcinoma II T2N1M0 Malignant
C2 32 F 47 Breast Invasive ductal carcinoma II~III T2N0M0 Malignant
C3 33 F 50 Breast Invasive ductal carcinoma II~III T2N1M0 Malignant
C4 34 F 51 Breast Invasive ductal carcinoma II T4N3Mx Malignant
C5 35 F 36 Breast Invasive ductal carcinoma II~III T3N1M0 Malignant
C6 36 F 66 Breast Invasive ductal carcinoma, tubular type I~II T2N0M0 Malignant
C7 37 F 50 Breast Invasive ductal carcinoma II T2N0M0 Malignant
C8 38 F 66 Breast Invasive ductal carcinoma III T2N1M0 Malignant
C9 39 F 61 Breast Ductal carcinoma in situ, papillary I~II T3N0M0 Malignant
C10 40 F 57 Breast Invasive ductal carcinoma II T2N1M0 Malignant
C11 41 F 60 Breast Invasive ductal carcinoma II~III T2N0M0 Malignant
C12 42 F 56 Breast Sarcoma T2N0M0 Malignant
C13 43 F 33 Breast Ductal carcinoma in situ I TisN0M0 Malignant
C14 44 F 40 Breast Invasive ductal carcinoma II T4N2Mx Malignant
C15 45 F 34 Breast Ductal carcinoma in situ I TisN0M0 Malignant
D1 46 F 55 Breast Invasive ductal carcinoma II T2N1M0 Malignant
D2 47 F 47 Breast Invasive ductal carcinoma II~III T2N0M0 Malignant
D3 48 F 50 Breast Invasive ductal carcinoma II~III T2N1M0 Malignant
D4 49 F 51 Breast Invasive ductal carcinoma II T4N3Mx Malignant
D5 50 F 36 Breast Invasive ductal carcinoma II~III T3N1M0 Malignant
D6 51 F 66 Breast Invasive ductal carcinoma, tubular type I~II T2N0M0 Malignant
D7 52 F 50 Breast Invasive ductal carcinoma II T2N0M0 Malignant
D8 53 F 66 Breast Invasive ductal carcinoma III T2N1M0 Malignant
D9 54 F 61 Breast Ductal carcinoma in situ, papillary I~II T3N0M0 Malignant
D10 55 F 57 Breast Invasive ductal carcinoma II T2N1M0 Malignant
D11 56 F 60 Breast Invasive ductal carcinoma II~III T2N0M0 Malignant
D12 57 F 56 Breast Sarcoma T2N0M0 Malignant
D13 58 F 33 Breast Ductal carcinoma in situ I TisN0M0 Malignant
D14 59 F 40 Breast Invasive ductal carcinoma II T4N2Mx Malignant
D15 60 F 34 Breast Ductal carcinoma in situ I TisN0M0 Malignant
E1 61 F 40 Breast Invasive ductal carcinoma II T2N0M0 Malignant
E2 62 F 50 Breast Invasive ductal carcinoma II~III T2N0M0 Malignant
E3 63 F 44 Breast Invasive ductal carcinoma I~II T2N0M0 Malignant
E4 64 F 58 Breast Invasive ductal carcinoma II T2N0M0 Malignant
E5 65 F 37 Breast Invasive ductal carcinoma II~III T4N1M0 Malignant
E6 66 F 61 Breast Invasive ductal carcinoma II~III T4N0M0 Malignant
E7 67 F 41 Breast Ductal carcinoma in situ I T2N0M0 Malignant
E8 68 F 28 Breast Invasive ductal carcinoma II T2N0M0 Malignant
E9 69 F 30 Breast Invasive ductal carcinoma II~III T2N2M0 Malignant
E10 70 F 52 Breast Invasive ductal carcinoma II~III T2N0M0 Malignant
E11 71 F 48 Breast Invasive ductal carcinoma III T2N0M0 Malignant
E12 72 F 43 Breast Invasive ductal carcinoma II T2N2M0 Malignant
E13 73 F 46 Breast Invasive ductal carcinoma II T2N0M0 Malignant
E14 74 F 68 Breast Invasive papillary carcinoma I~II T2N0M0 Malignant
E15 75 F 49 Breast Invasive ductal carcinoma II~III T2N0M0 Malignant
F1 76 F 40 Breast Invasive ductal carcinoma II T2N0M0 Malignant
F2 77 F 50 Breast Invasive ductal carcinoma II~III T2N0M0 Malignant
F3 78 F 44 Breast Invasive ductal carcinoma I~II T2N0M0 Malignant
F4 79 F 58 Breast Invasive ductal carcinoma II T2N0M0 Malignant
F5 80 F 37 Breast Invasive ductal carcinoma II~III T4N1M0 Malignant
F6 81 F 61 Breast Invasive ductal carcinoma II~III T4N0M0 Malignant
F7 82 F 41 Breast Ductal carcinoma in situ I T2N0M0 Malignant
F8 83 F 28 Breast Invasive ductal carcinoma II T2N0M0 Malignant
F9 84 F 30 Breast Invasive ductal carcinoma II~III T2N2M0 Malignant
F10 85 F 52 Breast Invasive ductal carcinoma II~III T2N0M0 Malignant
F11 86 F 48 Breast Invasive ductal carcinoma III T2N0M0 Malignant
F12 87 F 43 Breast Invasive ductal carcinoma II T2N2M0 Malignant
F13 88 F 46 Breast Invasive ductal carcinoma II T2N0M0 Malignant
F14 89 F 68 Breast Invasive papillary carcinoma I~II T2N0M0 Malignant
F15 90 F 49 Breast Invasive ductal carcinoma II~III T2N0M0 Malignant
G1 91 F 51 Breast Invasive ductal carcinoma II~III T2N0M0 Malignant
G2 92 F 45 Breast Invasive ductal carcinoma II~III T2N0M0 Malignant
G3 93 F 30 Breast Invasive ductal carcinoma III T2N0M0 Malignant
G4 94 F 54 Breast Invasive ductal carcinoma II T2N0M0 Malignant
G5 95 F 60 Breast Invasive ductal carcinoma II T2N0M0 Malignant
G6 96 F 44 Breast Invasive ductal carcinoma II~III T2N0M0 Malignant
G7 97 F 38 Breast Invasive ductal carcinoma II~III T2N2M0 Malignant
G8 98 F 43 Breast Invasive ductal carcinoma I T2N0M0 Malignant
G9 99 F 42 Breast Invasive ductal carcinoma II~III T2N0M0 Malignant
G10 100 F 55 Breast Invasive ductal carcinoma II T2N0M0 Malignant
G11 101 F 49 Breast Invasive ductal carcinoma II~III T2N0M0 Malignant
G12 102 F 41 Breast Ductal carcinoma in situ I T3N0M0 Malignant
G13 103 F 41 Breast Mucinous adenocarcinoma T3N0M0 Malignant
G14 104 F 41 Breast Invasive ductal carcinoma II~III T2N0M0 Malignant
G15 105 F 46 Breast Invasive ductal carcinoma II~III T4N0M0 Malignant
H1 106 F 51 Breast Invasive ductal carcinoma II~III T2N0M0 Malignant
H2 107 F 45 Breast Invasive ductal carcinoma II~III T2N0M0 Malignant
H3 108 F 30 Breast Invasive ductal carcinoma III T2N0M0 Malignant
H4 109 F 54 Breast Invasive ductal carcinoma II T2N0M0 Malignant
H5 110 F 60 Breast Invasive ductal carcinoma II T2N0M0 Malignant
H6 111 F 44 Breast Invasive ductal carcinoma II~III T2N0M0 Malignant
H7 112 F 38 Breast Invasive ductal carcinoma II~III T2N2M0 Malignant
H8 113 F 43 Breast Invasive ductal carcinoma I T2N0M0 Malignant
H9 114 F 42 Breast Invasive ductal carcinoma II~III T2N0M0 Malignant
H10 115 F 55 Breast Invasive ductal carcinoma II T2N0M0 Malignant
H11 116 F 49 Breast Invasive ductal carcinoma II~III T2N0M0 Malignant
H12 117 F 41 Breast Ductal carcinoma in situ I T3N0M0 Malignant
H13 118 F 41 Breast Mucinous adenocarcinoma T3N0M0 Malignant
H14 119 F 41 Breast Invasive ductal carcinoma II~III T2N0M0 Malignant
H15 120 F 46 Breast Invasive ductal carcinoma II~III T4N0M0 Malignant
I1 121 F 68 Breast Invasive ductal carcinoma II T4N0M0 Malignant
I2 122 F 49 Breast Invasive ductal carcinoma II~III T2N0M0 Malignant
I3 123 F 55 Breast Invasive ductal carcinoma II T2N0M0 Malignant
I4 124 F 44 Breast Invasive ductal carcinoma III T4N3Mx Malignant
I5 125 F 60 Breast Invasive ductal carcinoma II T2N0M0 Malignant
I6 126 F 43 Breast Invasive lobular carcinoma I~II T3N0M0 Malignant
I7 127 F 44 Breast Invasive ductal carcinoma II~III T3N0M0 Malignant
I8 128 F 42 Breast Invasive ductal carcinoma II T4N2M0 Malignant
I9 129 F 41 Breast Invasive ductal carcinoma II T3N0M0 Malignant
I10 130 F 56 Breast Invasive ductal carcinoma II~III T2N0M0 Malignant
I11 131 F 79 Breast Invasive ductal carcinoma II T2N0M0 Malignant
I12 132 F 57 Breast Invasive ductal carcinoma II T3N0M0 Malignant
I13 133 F 54 Breast Invasive lobular carcinoma I T4N3M1 Malignant
I14 134 F 33 Breast Invasive ductal carcinoma II T4N2M0 Malignant
I15 135 F 42 Breast Invasive ductal carcinoma II~III T2N0M0 Malignant
J1 136 F 68 Breast Invasive ductal carcinoma II T4N0M0 Malignant
J2 137 F 49 Breast Invasive ductal carcinoma II~III T2N0M0 Malignant
J3 138 F 55 Breast Invasive ductal carcinoma II T2N0M0 Malignant
J4 139 F 44 Breast Invasive ductal carcinoma III T4N3Mx Malignant
J5 140 F 60 Breast Invasive ductal carcinoma II T2N0M0 Malignant
J6 141 F 43 Breast Invasive lobular carcinoma I~II T3N0M0 Malignant
J7 142 F 44 Breast Invasive ductal carcinoma II~III T3N0M0 Malignant
J8 143 F 42 Breast Invasive ductal carcinoma II T4N2M0 Malignant
J9 144 F 41 Breast Invasive ductal carcinoma II T3N0M0 Malignant
J10 145 F 56 Breast Invasive ductal carcinoma II~III T2N0M0 Malignant
J11 146 F 79 Breast Invasive ductal carcinoma II T2N0M0 Malignant
J12 147 F 57 Breast Invasive ductal carcinoma II T3N0M0 Malignant
J13 148 F 54 Breast Invasive lobular carcinoma I T4N3M1 Malignant
J14 149 F 33 Breast Invasive ductal carcinoma II T4N2M0 Malignant
J15 150 F 42 Breast Invasive ductal carcinoma II~III T2N0M0 Malignant

*For precise diagnosis, refer to pathology description.

目次に戻る

カートに商品を
追加しました。

ヒト組織アレイのFAQ

US BIOMAX社ヒト組織アレイのFAQはこちら。

目次に戻る

カートに商品を
追加しました。

お問い合わせ先

（テクニカルサポート 試薬担当）

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。